Ethan Burns

512 total citations
45 papers, 301 citations indexed

About

Ethan Burns is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ethan Burns has authored 45 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in Ethan Burns's work include Cancer Immunotherapy and Biomarkers (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Ethan Burns is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Ethan Burns collaborates with scholars based in United States, United Kingdom and United Arab Emirates. Ethan Burns's co-authors include Kartik Anand, Sai Ravi Pingali, B. E. Walker, Joe Ensor, Barry Trachtenberg, Ibrahim N. Muhsen, Vivek Subbiah, Swaminathan P. Iyer, Lawrence Rice and Jiaqiong Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ethan Burns

39 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ethan Burns United States 9 136 57 51 42 36 45 301
Wusheng Lu China 12 96 0.7× 100 1.8× 83 1.6× 61 1.5× 8 0.2× 30 338
L. Guillevin France 9 69 0.5× 101 1.8× 37 0.7× 29 0.7× 65 1.8× 33 328
Weiwei Chen China 11 203 1.5× 68 1.2× 45 0.9× 63 1.5× 5 0.1× 43 445
Seema Khanna India 12 59 0.4× 149 2.6× 39 0.8× 52 1.2× 6 0.2× 45 368
Feliciano Chanana Paquissi Angola 7 49 0.4× 55 1.0× 121 2.4× 22 0.5× 13 0.4× 9 299
Hyun Hee Lee South Korea 8 30 0.2× 69 1.2× 38 0.7× 54 1.3× 14 0.4× 29 287
Fadi Braiteh United States 10 158 1.2× 44 0.8× 37 0.7× 85 2.0× 34 0.9× 19 389
Marjan Afrouzian United States 10 74 0.5× 142 2.5× 44 0.9× 48 1.1× 14 0.4× 21 396
Maham Hayat United States 11 92 0.7× 48 0.8× 32 0.6× 45 1.1× 28 0.8× 56 292

Countries citing papers authored by Ethan Burns

Since Specialization
Citations

This map shows the geographic impact of Ethan Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Burns more than expected).

Fields of papers citing papers by Ethan Burns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Burns. The network helps show where Ethan Burns may publish in the future.

Co-authorship network of co-authors of Ethan Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Ethan Burns. A scholar is included among the top collaborators of Ethan Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ethan Burns. Ethan Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Esmail, Abdullah, et al.. (2024). The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma. Journal of Clinical Medicine. 13(17). 4994–4994.
3.
Giese, Noah, et al.. (2024). Management Considerations and Challenges in Older Individuals with Diffuse Large B-cell Lymphoma. Medical Research Archives. 12(5).
4.
Burns, Ethan, Noah Giese, Chih-Hang Anthony Tang, et al.. (2024). Primary Vitreoretinal Lymphoma with or without Intracranial Involvement: A Single Center Experience. Blood. 144(Supplement 1). 1716–1716.
5.
Burns, Ethan, Ibrahim N. Muhsen, Chih‐Chi Andrew Hu, et al.. (2023). Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry. Annals of Hematology. 102(5). 1111–1120. 3 indexed citations
6.
Burns, Ethan, et al.. (2023). Treatment at Twilight: An Analysis of Therapy Patterns and Outcomes in Adults 80 Years and Older With Advanced or Metastatic NSCLC. JTO Clinical and Research Reports. 4(10). 100570–100570. 2 indexed citations
7.
Burns, Ethan, Justin J. Wilson, Zimu Gong, et al.. (2023). Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry. Annals of Hematology. 102(10). 2753–2763.
8.
Chitturi, Kalyan R., Ethan Burns, Ibrahim N. Muhsen, Kartik Anand, & Barry Trachtenberg. (2022). Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy. Current Oncology Reports. 24(4). 475–491. 14 indexed citations
9.
Yu, Kenneth H., Andrew Hendifar, Olatunji B. Alese, et al.. (2021). Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan. Frontiers in Oncology. 11. 678070–678070. 5 indexed citations
10.
Burns, Ethan, et al.. (2021). Outcomes and prognostic contributors in patients with KRAS mutated non-small cell pulmonary adenocarcinomas: a single institution experience. Journal of Thoracic Disease. 13(8). 4785–4796. 4 indexed citations
12.
Burns, Ethan, Ibrahim N. Muhsen, John Rogers, et al.. (2020). Primary and Secondary Central Nervous System Lymphoma: Outcomes from Houston Methodist Cancer Center. Blood. 136(Supplement 1). 16–17.
13.
Kasparian, Saro, et al.. (2020). Recurrent small bowel obstruction caused by Burkitt lymphoma in an elderly man: a case report and review of the literature. Journal of Medical Case Reports. 14(1). 127–127. 4 indexed citations
14.
Anand, Kartik, Ethan Burns, Joe Ensor, et al.. (2020). Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors. ESMO Open. 5(4). e000866–e000866. 44 indexed citations
15.
Burns, Ethan, et al.. (2020). Pancreatic adenocarcinoma with early esophageal metastasis: A case report and review of literature. World Journal of Clinical Oncology. 11(2). 83–90. 2 indexed citations
16.
Burns, Ethan, et al.. (2020). The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: a report of three cases. ecancermedicalscience. 14. 1011–1011. 1 indexed citations
17.
Reddy, T. P., Usman Khan, Ethan Burns, & Maen Abdelrahim. (2020). Chemotherapy rechallenge in metastatic colon cancer: A case report and literature review. World Journal of Clinical Oncology. 11(11). 959–967. 7 indexed citations
18.
Anand, Kartik, Ethan Burns, Joe Ensor, Lawrence Rice, & Sai Ravi Pingali. (2019). Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review. Clinical Lymphoma Myeloma & Leukemia. 20(1). 18–23. 21 indexed citations
19.
Burns, Ethan, et al.. (2019). A Case of Histiocytic Sarcoma Arising from Mycosis Fungoides. SHILAP Revista de lepidopterología. 2019. 1–7. 1 indexed citations
20.
Burns, Ethan, et al.. (2018). Trends in the Body Mass Index of Pediatric and Adult Patients Undergoing Anterior Cruciate Ligament Reconstruction. Orthopaedic Journal of Sports Medicine. 6(4). 1809814822–1809814822. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026